These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 1000512
1. Ambiguity of the thymidine index. Simpson-Herren L, Sanford AH, Holmquist JP, Springer TA, Lloyd HH. Cancer Res; 1976 Dec; 36(12):4705-9. PubMed ID: 1000512 [Abstract] [Full Text] [Related]
3. The effects of counting threshold and emulsion exposure duration on the percent-labeled mitosis curve and their implications for cell cycle analysis. Shackney SE, Ford SS, Wittig AB. Cancer Res; 1973 Nov; 33(11):2726-31. PubMed ID: 4795901 [No Abstract] [Full Text] [Related]
4. In vitro labeling and gold activation autoradiography for determination of labeling index and DNA synthesis times of solid tumors. Braunschweiger PG, Poulakos L, Schiffer LM. Cancer Res; 1976 May; 36(5):1748-53. PubMed ID: 1268832 [Abstract] [Full Text] [Related]
5. Variations in the [3H]thymidine labeling of S-phase cells in solid mouse tumors. Allison DC, Ridolpho PF, Anderson S, Bose K. Cancer Res; 1985 Dec; 45(12 Pt 1):6010-6. PubMed ID: 4063961 [Abstract] [Full Text] [Related]
6. [The effect of sarcolysine on utilization of H3-thymidine by cells of transplantable tumors in vitro]. Kas'ianenko VV. Vopr Onkol; 1968 Dec; 14(1):51-5. PubMed ID: 5660341 [No Abstract] [Full Text] [Related]
7. [Clonogenic capacity of proliferating and resting populations of NKLy/LL tumor cells]. Timcheva KV, Pelevina II. Vopr Onkol; 1981 Dec; 27(2):55-60. PubMed ID: 7210596 [Abstract] [Full Text] [Related]
10. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine. Cook JA, Glass J, Lebovics R, Bobo H, Pass H, DeLaney TF, Oldfield EH, Mitchell JB, Glatstein E, Goffman TE. Cancer Res; 1992 Feb 01; 52(3):719-25. PubMed ID: 1732059 [Abstract] [Full Text] [Related]
13. Quantitative determination of disseminated tumor cells by [3H]thymidine incorporation in vitro and by agar colony formation. Schirrmacher V, Waller CA. Cancer Res; 1982 Feb 01; 42(2):660-6. PubMed ID: 7034926 [Abstract] [Full Text] [Related]
15. Estimation of tumor growth fraction in murine tumors by the primer-available DNA-dependent DNA polymerase assay. Schiffer LM, Markoe AM, Nelson JS. Cancer Res; 1976 Jul 01; 36(7 PT 1):2415-8. PubMed ID: 1277147 [Abstract] [Full Text] [Related]
16. Differentiation of malignant to benign cells. Pierce GB, Wallace C. Cancer Res; 1971 Feb 01; 31(2):127-34. PubMed ID: 5545265 [No Abstract] [Full Text] [Related]
17. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells. Williams RM, Germain RN, Benacerraf B. J Natl Cancer Inst; 1975 Mar 01; 54(3):697-708. PubMed ID: 1091740 [Abstract] [Full Text] [Related]
18. Twenty-four-hour variations in DNA synthesis of a fast-growing and a slow-growing hepatoma: DNA synthesis rhythm in hepatoma. Nash RE, Llanos JM. J Natl Cancer Inst; 1971 Nov 01; 47(5):1007-12. PubMed ID: 4330794 [No Abstract] [Full Text] [Related]
19. DNA synthesis in fast- and slow-growing C57BL ascites tumors. Maruyama Y, Gedgaudes RK, Lee TC, Yung WK. Cancer Res; 1974 Oct 01; 34(10):2580-4. PubMed ID: 4412879 [No Abstract] [Full Text] [Related]
20. Cell proliferation and carcinogenesis in the hamster cheek pouch. Reiskin AB, Berry RJ. Cancer Res; 1968 May 01; 28(5):898-905. PubMed ID: 5652303 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]